Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

ACC 2024 Congress

Catch up on all the top stories and latest evidence in cardiology research with our ACC 2024 Congress hub page.
ADVANCED SEARCH
Log in
Top
Urolithiasis
Published in: Urolithiasis 6/2012

01-12-2012 | Original Paper

Protective effect of Flos carthami extract against ethylene glycol-induced urolithiasis in rats

Authors: Wu-Chou Lin, Ming-Tsung Lai, Huey-Yi Chen, Chien-Yi Ho, Kee-Ming Man, Jui-Lung Shen, Yuan-Ju Lee, Fuu-Jen Tsai, Yung-Hsiang Chen, Wen-Chi Chen

Published in: Urolithiasis | Issue 6/2012

Login to get access

Abstract

Flos carthami (FC), also known as Carthamus tinctorius, is a traditional Chinese herbal plant that has been prescribed since centuries for treating various symptoms related to blood circulation improvement. This study aimed to investigate the effects of FC on calcium oxalate (CaOx) formation in ethylene glycol (EG)-fed rats. A total of 50 male Sprague–Dawley rats were divided into the following 6 groups: group 1, as the normal control (n = 5); group 2 received gastric gavages of starch and 0.75% EG (placebo, n = 5) as a stone inducer; group 3 (n = 10) received EG and potassium citrate as positive controls; group 4 (n = 10) received 0.75% EG and 300 mg/day FC; group 5 (n = 10) was treated with EG and 600 mg/day FC; group 6 (n = 10) received with EG and 1,200 mg/day FC. For all experimental animals, 24-h urine and blood samples were analyzed at the beginning and end of the experiment. Kidney tissue was histopathologically examined using a polarized light microscope, and crystal deposits were evaluated by a semi-quantitative scoring method; these scores were significantly lower in the FC groups (600 and 1,200 mg/day) than in the placebo group. Thus, FC administration appeared to inhibit the deposition of CaOx crystal EG-fed rats. We, therefore, consider that FC may be effective for preventing stone disease, albeit with certain side effects, such as a bleeding tendency. Further clinical trials are needed for evaluating its benefits and possible side effects.
Literature
1.
Lee YH, Huang WC, Tsai JY, Lu CM, Chen WC, Lee MH, Hsu HS, Huang JK, Chang LS (2002) Epidemiological studies on the prevalence of upper urinary calculi in Taiwan. Urol Int 68:172–177PubMedCrossRef
2.
Bansal AD, Hui J, Goldfarb DS (2009) Asymptomatic nephrolithiasis detected by ultrasound. Clin J Am Soc Nephrol 4:680–684PubMedCrossRef
3.
Sowers MR, Jannausch M, Wood C, Pope SK, Lachance LL, Peterson B (1998) Prevalence of renal stones in a population-based study with dietary calcium, oxalate, and medication exposures. Am J Epidemiol 147:914–920PubMedCrossRef
4.
Goldfarb DS (2003) Increasing prevalence of kidney stones in the United States. Kidney Int 63:1951–1952PubMedCrossRef
5.
Brikowski TH, Lotan Y, Pearle MS (2008) Climate-related increase in the prevalence of urolithiasis in the United States. Proc Natl Acad Sci U S A 105:9841–9846PubMedCrossRef
6.
Lee YH, Huang WC, Tsai JY, Huang JK (1999) The efficacy of potassium citrate based medical prophylaxis for preventing upper urinary tract calculi: a midterm followup study. J Urol 161:1453–1457PubMedCrossRef
7.
Tsai CH, Chen YC, Chen LD, Pan TC, Ho CY, Lai MT, Tsai FJ, Chen WC (2008) A traditional Chinese herbal antilithic formula, Wulingsan, effectively prevents the renal deposition of calcium oxalate crystal in ethylene glycol-fed rats. Urol Res 36:17–24PubMedCrossRef
8.
Tsai CH, Pan TC, Lai MT, Lee SC, Chen ML, Jheng JR, Chen WC (2009) Prophylaxis of experimentally induced calcium oxalate nephrolithiasis in rats by Zhulingtang, a traditional Chinese herbal formula. Urol Int 82:464–471PubMedCrossRef
9.
Yasui T, Fujita K, Sato M, Sugimoto M, Iguchi M, Nomura S, Kohri K (1999) The effect of takusha, a kampo medicine, on renal stone formation and osteopontin expression in a rat urolithiasis model. Urol Res 27:194–199PubMedCrossRef
10.
Atmani F, Khan SR (2000) Effects of an extract from Herniaria hirsuta on calcium oxalate crystallization in vitro. BJU Int 85:621–625PubMedCrossRef
11.
Freitas AM, Schor N, Boim MA (2002) The effect of Phyllanthus niruri on urinary inhibitors of calcium oxalate crystallization and other factors associated with renal stone formation. BJU Int 89:829–834PubMedCrossRef
12.
Liu QL, Sato S, Kishikawa T, Matsuzaki H, Yamanaka N (2001) Effectiveness of a traditional Chinese medicine, Wulingsan, in suppressing the development of nephrocalcinosis induced by a high phosphorus diet in young rats. Med Electron Microsc 34:103–114PubMedCrossRef
13.
Koide T, Yamaguchi S, Utsunomiya M, Yoshioka T, Sugiyama K (1995) The inhibitory effect of kampou extracts on in vitro calcium oxalate crystallization and in vivo stone formation in an animal model. Int J Urol 2:81–86PubMedCrossRef
14.
Al-Ghamdi SS, Al-Ghamdi AA, Shammah AA (2007) Inhibition of calcium oxalate nephrotoxicity with Cymbopogon schoenanthus (Al-Ethkher). Drug Metab Lett 1:241–244PubMedCrossRef
15.
Chen YH, Liu HP, Chen HY, Tsai FJ, Chang CH, Lee YJ, Lin WY, Chen WC (2011) Ethylene glycol induces calcium oxalate crystal deposition in Malpighian tubules: a Drosophila model for nephrolithiasis/urolithiasis. Kidney Int 80:369–377PubMedCrossRef
16.
Knauf F, Preisig PA (2011) Drosophila: a fruitful model for calcium oxalate nephrolithiasis? Kidney Int 80:327–329PubMedCrossRef
17.
Li Y, Che Q (1998) Studies on chemical components of Carthamus tinctorius petals. Yao Xue Xue Bao 33:626–628PubMed
18.
Sun M, Zhang JJ, Shan JZ, Zhang H, Jin CY, Xu S, Wang YL (2009) Clinical observation of Danhong Injection (herbal TCM product from Radix Salviae miltiorrhizae and Flos Carthami tinctorii) in the treatment of traumatic intracranial hematoma. Phytomedicine 16:683–689PubMedCrossRef
19.
Lu Y, Hu YL, Kong XF, Wang DY (2008) Selection of component drug in activating blood flow and removing blood stasis of Chinese herbal medicinal formula for dairy cow mastitis by hemorheological method. J Ethnopharmacol 116:313–317PubMedCrossRef
20.
Zhang S, Xu C (1997) Progress in the clinical uses of flos Carthami. Zhongguo Zhong Yao Za Zhi 22:439–440, 442
21.
Li HX, Han SY, Wang XW, Ma X, Zhang K, Wang L, Ma ZZ, Tu PF (2009) Effect of the carthamins yellow from Carthamus tinctorius L. on hemorheological disorders of blood stasis in rats. Food Chem Toxicol 47:1797–1802PubMedCrossRef
22.
Reagan-Shaw S, Nihal M, Ahmad N (2008) Dose translation from animal to human studies revisited. FASEB J 22:659–661PubMedCrossRef
23.
Lee YH, Huang WC, Chiang H, Chen MT, Huang JK, Chang LS (1992) Determinant role of testosterone in the pathogenesis of urolithiasis in rats. J Urol 147:1134–1138PubMed
24.
McMartin K (2009) Are calcium oxalate crystals involved in the mechanism of acute renal failure in ethylene glycol poisoning? Clin Toxicol (Phila) 47:859–869CrossRef
25.
Khan SR, Glenton PA, Byer KJ (2007) Dietary oxalate and calcium oxalate nephrolithiasis. J Urol 178:2191–2196PubMedCrossRef
26.
Khan SR, Glenton PA, Byer KJ (2006) Modeling of hyperoxaluric calcium oxalate nephrolithiasis: experimental induction of hyperoxaluria by hydroxy-l-proline. Kidney Int 70:914–923PubMedCrossRef
27.
Khan SR, Johnson JM, Peck AB, Cornelius JG, Glenton PA (2002) Expression of osteopontin in rat kidneys: induction during ethylene glycol induced calcium oxalate nephrolithiasis. J Urol 168:1173–1181PubMedCrossRef
28.
Jammalamadaka D, Raissi S (2010) Ethylene glycol, methanol and isopropyl alcohol intoxication. Am J Med Sci 339:276–281PubMedCrossRef
29.
Green ML, Hatch M, Freel RW (2005) Ethylene glycol induces hyperoxaluria without metabolic acidosis in rats. Am J Physiol Renal Physiol 289:F536–F543PubMedCrossRef
30.
Selvam R, Kalaiselvi P, Govindaraj A, Bala Murugan V, Sathish Kumar AS (2001) Effect of A. lanata leaf extract and Vediuppu chunnam on the urinary risk factors of calcium oxalate urolithiasis during experimental hyperoxaluria. Pharmacol Res 43:89–93PubMedCrossRef
31.
Araujo Viel T, Diogo Domingos C, da Silva Monteiro AP, Riggio Lima-Landman MT, Lapa AJ, Souccar C (1999) Evaluation of the antiurolithiatic activity of the extract of Costus spiralis Roscoe in rats. J Ethnopharmacol 66:193–198PubMedCrossRef
32.
Gohel MD, Wong SP (2006) Chinese herbal medicines and their efficacy in treating renal stones. Urol Res 34:365–372PubMedCrossRef
33.
Cao ZG, Liu JH, Zhou SW, Wu W, Yin CP, Wu JZ (2004) The effects of the active constituents of Alisma orientalis on renal stone formation and bikunin expression in rat urolithiasis model. Zhonghua Yi Xue Za Zhi 84:1276–1279PubMed
34.
Yoshimura K, Miyake O, Okuyama A, Yoshioka T, Honda M, Yamaguchi S, Koide T (1998) Effect of chorei-to and gorei-san on calcium oxalate crystallization in human urine. Hinyokika Kiyo 44:13–16PubMed
35.
Miyaoka R, Monga M (2009) Use of traditional Chinese medicine in the management of urinary stone disease. Int Braz J Urol 35:396–405PubMedCrossRef
36.
Cao ZG, Liu JH, Radman AM, Wu JZ, Ying CP, Zhou SW (2003) An experimental study of effect of different extracts of Alisma orientalis on urinary calcium oxalate stones formation in rats. Zhongguo Zhong Yao Za Zhi 28:1072–1075PubMed
37.
Butterweck V, Khan SR (2009) Herbal medicines in the management of urolithiasis: alternative or complementary? Planta Med 75:1095–1103PubMedCrossRef
38.
Atmani F (2003) Medical management of urolithiasis, what opportunity for phytotherapy? Front Biosci 8:s507–s514PubMedCrossRef
Metadata
Title
Protective effect of Flos carthami extract against ethylene glycol-induced urolithiasis in rats
Authors
Wu-Chou Lin
Ming-Tsung Lai
Huey-Yi Chen
Chien-Yi Ho
Kee-Ming Man
Jui-Lung Shen
Yuan-Ju Lee
Fuu-Jen Tsai
Yung-Hsiang Chen
Wen-Chi Chen
Publication date
01-12-2012
Publisher
Springer-Verlag
Published in
Urolithiasis / Issue 6/2012
Print ISSN: 2194-7228
Electronic ISSN: 2194-7236
DOI
https://doi.org/10.1007/s00240-012-0472-4

Other articles of this Issue 6/2012

Urolithiasis 6/2012 Go to the issue

Original Paper

Unique surface and internal structure of struvite crystals formed by Proteus mirabilis

Invited Review

Flexible ureterorenoscopic management of upper tract pathologies

Erratum

Erratum to: Morphological and immunological characteristics of nanobacteria from human renal stones of a north Indian population

Original Paper

Immediate or delayed SWL in ureteric stones: a prospective and randomized study

Letter to the Editor

Spontaneous stone passage: is it Ammi visnaga effect?

Original Paper

Hyperoxaluric rats do not exhibit alterations in renal expression patterns of Slc26a1 (SAT1) mRNA or protein